Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modelling #28
Annotations
1 notice
|
Journal publications table
Year|Title|URL|Source|DOI
-|-|-|-|-
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/750">Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modelling</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41588614/">https://pubmed.ncbi.nlm.nih.gov/41588614/</a>|Br J Clin Pharmacol. 2026 Jun;92(6):1845-1856.|<a href="https://doi.org/10.1002/bcp.70443">10.1002/bcp.70443</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/749">Physiologically Based Pharmacokinetic Modeling of Digoxin in Adult and Pediatric Patients with Heart Failure</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41599219/">https://pubmed.ncbi.nlm.nih.gov/41599219/</a>|Pharmaceutics. 2026 Jan 15;18(1):112.|<a href="https://doi.org/10.3390/pharmaceutics18010112">10.3390/pharmaceutics18010112</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/748">Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41639518/">https://pubmed.ncbi.nlm.nih.gov/41639518/</a>|Pharm Res. 2026 Feb;43(2):345-355.|<a href="https://doi.org/10.1007/s11095-026-04023-5">10.1007/s11095-026-04023-5</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/747">PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41758322/">https://pubmed.ncbi.nlm.nih.gov/41758322/</a>|Arch Pharm Res. 2026 Feb;49(2):278-291.|<a href="https://doi.org/10.1007/s12272-026-01600-5">10.1007/s12272-026-01600-5</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/746">Predicting Cumulative Neonatal Sodium Benzoate Exposures During Breastfeeding with Physiologically Based Pharmacokinetic Modelling</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41758461/">https://pubmed.ncbi.nlm.nih.gov/41758461/</a>|Clin Pharmacokinet. 2026 May;65(5):665-680.|<a href="https://doi.org/10.1007/s40262-026-01624-6">10.1007/s40262-026-01624-6</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/745">Physiologically based pharmacokinetic modeling of immediate-release and extended-release formulations of doxazosin, an alpha-1 adrenergic receptor antagonist, with model simulations for patients with liver disease</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41874609/">https://pubmed.ncbi.nlm.nih.gov/41874609/</a>|Naunyn Schmiedebergs Arch Pharmacol. 2026 Mar 24.|<a href="https://doi.org/10.1007/s00210-026-05191-2">10.1007/s00210-026-05191-2</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/744">Physiology-Based Pharmacokinetic Modeling for Prediction of Gentamicin Plasma Profile in Dogs with Renal Dysfunction</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41900793/">https://pubmed.ncbi.nlm.nih.gov/41900793/</a>|Pharmaceutics. 2026 Feb 28;18(3):308.|<a href="https://doi.org/10.3390/pharmaceutics18030308">10.3390/pharmaceutics18030308</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/743">Physiologically Based Pharmacokinetic Model for Fluzoparib Among Patients With Renal Impairment</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/41945076/">https://pubmed.ncbi.nlm.nih.gov/41945076/</a>|Clin Ther. 2026 Jun;48(6):487-494.|<a href="https://doi.org/10.1016/j.clinthera.2026.03.013">10.1016/j.clinthera.2026.03.013</a>
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/742">Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/42076117/">https://pubmed.ncbi.nlm.nih.gov/420761
|